NIAID- VRC HIV mAb-Research, Development, and Production to Support HIV Monoclonal Antibody Developm — DAVID LINDSAY (LEIDOS BIOME
The NIAID mission and scope includes rapidly responding to infectious disease outbreaks through research, development, and testing of HIV vaccines and therapeutics
| Project title | NIAID- VRC HIV mAb-Research, Development, and Production to Support HIV Monoclonal Antibody Developm |
|---|---|
| Project number | 75N91019D00024-P00001-759102200001-1 |
| PI name | DAVID LINDSAY |
| Institution | LEIDOS BIOMEDICAL RESEARCH, INC. |
| Funding mechanism | N01 |
| Agency | NIAID |
| Award amount | $13.15M |
| Fiscal year | 2022 |
| Project start | 2022-02-01T00:00:00 |
| Project end | 2027-08-14T00:00:00 |
| Abstract | The NIAID mission and scope includes rapidly responding to infectious disease outbreaks through research, development, and testing of HIV vaccines and therapeutics |
| Key terms | <AIDS Virus><AIDS test><AIDS/HIV test><Ab-mediated immunity><Ab-mediated protection><Acquired Immune |
$799/mo
Try GrantRadar →